Trials / Completed
CompletedNCT02558335
CTCs for High Grade Glioma
Circulating Tumor Markers for High Grade Glioma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to identify and quantify circulating tumor markers, which are associated with the presence of tumors. The current imaging available does not allow specificity of tumor size as it relates to pseudoprogression (a temporary enlargement or "swelling" of the tumor after treatment before it shrinks). Our hope is that CTCs will provide a more accurate description of tumor state for high grade glioma patients.
Conditions
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2017-04-01
- Completion
- 2020-04-01
- First posted
- 2015-09-24
- Last updated
- 2020-04-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02558335. Inclusion in this directory is not an endorsement.